
Immunotherapy Answers the Call to Fight the COVID-19 Virus
Author(s) -
Mark L. Fuerst
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000666552.67897.c4
Subject(s) - medicine , pneumonitis , immunotherapy , lung cancer , covid-19 , cytokine release syndrome , atezolizumab , cancer , immunology , intensive care medicine , pembrolizumab , lung , infectious disease (medical specialty) , disease , chimeric antigen receptor